Zoledronic acid Good Manufacturer supply High Quality 118072-93-8
- Molecular Formula:C5H10N2O7P2
- Molecular Weight:316.055
- Appearance/Colour:white crystalline powder
- Vapor Pressure:1.53E-24mmHg at 25°C
- Melting Point:193-2040 ºC
- Refractive Index:1.718
- Boiling Point:764 ºC at 760 mmHg
- PKA:1.41±0.10(Predicted)
- Flash Point:415.8 ºC
- PSA：172.73000
- Density:2.13 g/cm3
- LogP:-1.11540
Zoledronic acid (118072-93-8) Usage
Zoledronic acid is a white, crystalline powder that is available in vials for reconstitution for IV infusion over at least 15 minutes. It does not undergo metabolic transformation and does not inhibit CYP450 enzymes. Clearance of this agent is dependent on the patient's creatinine clearance, not on dose. Serum creatinine levels should be evaluated before every treatment. Zolendronic acid is contraindicated in patients with severe renal impairment.
How to get the best price on Zoledronic acid?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Zoledronic acid . You can buy high quality, low price Zoledronic acid 118072-93-8 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
